Virologic re-suppression and the associated factors among children aged 1-9 years on Antiretroviral Therapy in The Aids Support Organization Soroti Region, Uganda: a retrospective cohort analysis
Winfred Ruth Acham, Aisha Nalugya, Ricky Nyatia, Nelson Bunani
{"title":"Virologic re-suppression and the associated factors among children aged 1-9 years on Antiretroviral Therapy in The Aids Support Organization Soroti Region, Uganda: a retrospective cohort analysis","authors":"Winfred Ruth Acham, Aisha Nalugya, Ricky Nyatia, Nelson Bunani","doi":"10.4314/ahs.v24i2.2","DOIUrl":null,"url":null,"abstract":"Background: Children living with HIV experience low viral load re-suppression after a high viral load compared to the rest of the population. We determined the proportion with re-suppressed viral load and associated factors among children 1-9 years on Antiretroviral Therapy (ART) in The Aids Support Organization (TASO) Soroti Region. \nMethods: We conducted a retrospective cohort analysis of 401 records of children that initially had high viral load > 1000copies/ml for the period January 2016 to December 2018. Modified Poisson regression was performed to determine factors associated with virologic re-suppression. \nResults: The prevalence of virologic re-suppression was 97/401 (24.2%). More than half, 213 (53.1%) of the children were females and 197/401 (49%) were aged between 8 and 9 years. Factors associated with virologic re-suppression were; being on protease inhibitor (PI) based regimen [APR 2.87, 95% CI 1.76-4.79], good adherence [APR1.71, 95% CI 1.22-2.51] and caregiver HIV seropositive status [APR 2.56, 95% CI 1.69-3.91]. \nConclusion: Virologic re-suppression was low compared to the UNAIDS target. Taking PI-based regimen, good adherence and HIV seropositive status of the caregiver were predictors of virologic re-suppression. Close viral load monitoring of children on ART and intensified targeted adherence support to caregivers is vital to improving virologic re-suppression. \nKeywords: Virologic re-suppression; Human Immunodeficiency Virus; children.","PeriodicalId":94295,"journal":{"name":"African health sciences","volume":"78 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"African health sciences","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.4314/ahs.v24i2.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Children living with HIV experience low viral load re-suppression after a high viral load compared to the rest of the population. We determined the proportion with re-suppressed viral load and associated factors among children 1-9 years on Antiretroviral Therapy (ART) in The Aids Support Organization (TASO) Soroti Region.
Methods: We conducted a retrospective cohort analysis of 401 records of children that initially had high viral load > 1000copies/ml for the period January 2016 to December 2018. Modified Poisson regression was performed to determine factors associated with virologic re-suppression.
Results: The prevalence of virologic re-suppression was 97/401 (24.2%). More than half, 213 (53.1%) of the children were females and 197/401 (49%) were aged between 8 and 9 years. Factors associated with virologic re-suppression were; being on protease inhibitor (PI) based regimen [APR 2.87, 95% CI 1.76-4.79], good adherence [APR1.71, 95% CI 1.22-2.51] and caregiver HIV seropositive status [APR 2.56, 95% CI 1.69-3.91].
Conclusion: Virologic re-suppression was low compared to the UNAIDS target. Taking PI-based regimen, good adherence and HIV seropositive status of the caregiver were predictors of virologic re-suppression. Close viral load monitoring of children on ART and intensified targeted adherence support to caregivers is vital to improving virologic re-suppression.
Keywords: Virologic re-suppression; Human Immunodeficiency Virus; children.
背景:与其他人群相比,感染艾滋病毒的儿童在高病毒载量后的病毒载量再抑制率较低。我们确定了索罗提地区艾滋病支持组织(TASO)中接受抗逆转录病毒疗法(ART)的 1-9 岁儿童中病毒载量再抑制的比例及相关因素。方法我们对2016年1月至2018年12月期间最初病毒载量大于1000copies/ml的401名儿童记录进行了回顾性队列分析。进行了修正泊松回归,以确定与病毒学再抑制相关的因素。结果:病毒学再抑制的发生率为 97/401(24.2%)。213名(53.1%)儿童中一半以上为女性,197/401(49%)名儿童的年龄在8至9岁之间。与病毒学再抑制相关的因素有:使用蛋白酶抑制剂(PI)治疗方案[APR 2.87,95% CI 1.76-4.79]、良好的依从性[APR1.71,95% CI 1.22-2.51]和照顾者的艾滋病毒血清反应呈阳性[APR 2.56,95% CI 1.69-3.91]。结论与联合国艾滋病规划署的目标相比,病毒再抑制率较低。采取以 PI 为基础的治疗方案、良好的依从性和照顾者的 HIV 血清阳性状况是病毒学再抑制的预测因素。对接受抗逆转录病毒疗法的儿童进行密切的病毒载量监测,并对护理人员加强有针对性的依从性支持,对于改善病毒再抑制至关重要。关键词病毒再抑制;人类免疫缺陷病毒;儿童。